Best Leukemia hematologist-oncologists in Spain: TOP 7 doctors

• Dr. Isabel Badell Serra specializes in leukemia treatment and bone marrow transplantation for children.
• She manages leukemia using chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation.
• Dr. Badell Serra has trained at medical institutions in Spain, the United States, and the United Kingdom.
• She is certified in Pediatric Hematology and Oncology, maintaining high standards in leukemia care.
• Fluent in English, Spanish, and Catalan, Dr. Badell Serra effectively communicates with a wide range of patients.

• Dr. Susana Rives Sola specializes in leukemia treatment and bone marrow transplantation for children.
• Utilizes chemotherapy, radiation therapy, targeted therapy, immunotherapy, and stem cell transplant.
• Has experience practicing at medical institutions in Spain, the United States, and Germany.
• Member of the European Society for Blood and Marrow Transplantation (EBMT).
• Speaks Spanish, English, and German fluently.

• Dr. Jaume Mora Graupera specializes in leukemia treatment in pediatric patients.
• Standard treatment options include chemotherapy, targeted therapy, immunotherapy, and stem cell transplant.
• International training at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA.
• Member of the International Society of Pediatric Oncology (SIOP) and the American Society of Clinical Oncology.
• Heads the Hematology Oncology Department at Sant Joan De Déu — Barcelona Children’s Hospital.

Dr. Jaime Pérez de Oteyza is a Spanish hematologist and heads the Hematology and Hematology Oncology Department at HM Hospitales Group. He is an expert in diagnostics and treatment of hematology conditions and hematopoietic stem cell transplant, and has taken part in the first bone marrow transplant in Spain. He holds a degree in general medicine from CEU San Pablo University, has trained in lymphomas pathology at Kiel University, and has a specialty in hematology and hemotherapy from the University of Alcalá. He has won numerous awards for his scientific research and has published over 40 papers on his studies. He is a member of the Spanish Hematology and Hemotherapy Society.

Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.